Clinical Science

Jason Watts, MD, PhD - 2020 ASN-Harold Amos Medical Faculty Development Program Recipient

Name: Jason Watts, MD, PhDWatts_photo_0.jpg

Institution: University of Michigan

Grant: 2020 ASN-Harold Amos Medical Faculty Development Program Recipient

Project Title: Regulatory Mechanism of RNA Polymerase Pausing Affects Gene Expression in the Kidney

 

How would you sum up your research in one sentence?

Q&As with KidneyCure Grant Recipients 2020

ASN_Foundation_Logo-Color (1).jpgThe following articles are brief Q&A sessions with KidneyCure (ASN Foundation) grant recipients. The sessions explore what research the individual is undertaking with the grant funds, their hopes for the research, career goals, and advice for others interested in applying for these grant funds.

ASN Pre-Doctoral Fellowship Award

ASN Releases a Statement on Gender Equality, Stands with Members of the LGBTQ+ Community

The American Society of Nephrology (ASN) stands with members of the LGBTQ+ community to continue to work to improve diversity, inclusiveness, and equity for members, patients, and the kidney community at large.

On Monday, June 15, 2020 the U.S. Supreme Court ruled that civil rights law protects gay and transgender workers from workplace discrimination, extending workplace protections to millions across the nation. While this is a wonderful victory for the LGBTQ community, steps backward in other areas continue to undermine LGBTQ equality.

New Nephrology and Hospice & Palliative Medicine Fellowship Training Programs Approved at Select US Universities

The Nephrology and Hospice & Palliative Medicine fellowship training programs of the University of Pennsylvania, Yale University, and the University of North Carolina have collaborated to create a combined 2-year training program through the ACGME’s Advancing Innovation in Residency Education (AIRE) program.

ASN President Agarwal and NKF President Kramer call for increased investment for prevention and research in COVID-19 and kidney disease relationship

In an editorial released on June 23rd by The Hill ASN President Anupam Agarwal, MD, FASN and NKF President Kramer, MD, MPH expressed that the intersection of COVID-19 and kidney disease is fraught with potential calamities and investment for prevention and research are necessary.

Minority Kidney Patients at Increased Risk for COVID-19 Due to Longstanding Structural Inequities

The statistics are startling. As of April 20, African Americans were far more likely than whites to become infected with SARS-CoV-2 and die from COVID-19.

Significant Update from CMS on Voluntary Models and ESCOs, Including Q&A

The Kidney Care Choices (KCC) Model, also known as the “voluntary model”, is moving forward beginning April 1, 2021 – a delay from the original start date of January 1, 2021 – due to the Public Health Emergency (PHE). The Centers for Medicare & Medicaid Services (CMS) Innovation Center announced that in addition to delaying the start of the model, the agency will also provide a second window for applications in 2021 for new participants with a starting date for that group of January 1, 2022.

ASN Issues a Statement Against Racism

The following statement was released today:

Washington, DC (June 1, 2020)—The American Society of Nephrology (ASN) is proud of its efforts to promote diversity, equity, and inclusion among kidney health professionals. This commitment is hollow, however, if ASN fails to oppose racism. ASN strongly supports and will advance efforts to achieve equality to reduce the adverse impact of racism, especially on health and in health care.

ASN Encourages Fellowship Programs to Conduct Interviews Remotely

The American Society of Nephrology (ASN) recognizes that the current coronavirus pandemic has placed unique demands on frontline caregivers, necessitated restrictions on travel, and imposed limitations on individuals with various health conditions.

Research Crucial to Combatting Effects of COVID-19 on Kidneys, Kidney Patients

Jan Carrousel 02.jpgAlthough widely thought of as a respiratory ailment, COVID-19 has demonstrated its ability to impact multiple organs. For those with existing kidney disease, the dangers of the SARS-CoV-2 coronavirus are especially stark.

Pages